Ghrelin
Ghrelin is a pharmaceutical drug with 22 clinical trials. Historical success rate of 94.4%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
89.5%
17 of 19 finished
10.5%
2 ended early
0
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Ghrelin Administration on Dopamine and Effort
Effects of Ghrelin Administration on Motivation
Unacylated Ghrelin to Improve Functioning in PAD
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure
Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin
Clinical Trials (22)
Effects of Ghrelin Administration on Dopamine and Effort
Effects of Ghrelin Administration on Motivation
Unacylated Ghrelin to Improve Functioning in PAD
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure
Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin
The Importance of Ghrelin for Glucose Metabolism After Sleeve Gastrectomy
Effect of Ghrelin on Sympathetic Nervous System
RCT of Ghrelin in Stroke Patients
Effect of Ghrelin on Decision-Making
Ghrelin Plus Strength Training in Frail Elderly Study
Preprandial Ghrelin Effect
Ghrelintrial With Patients With Stroke
Influence of Dairy Protein Breakfast on Glycemia, Weight Loss and Clock Genes in T2D
Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Ghrelin Repeated Dose Study
Effects of Ghrelin on Alcohol Cue Reactivity and Craving
Ghrelin in Cystic Fibrosis
Ghrelin - A Possible Opportunity to Improve Appetite
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22